middle.news
OncoSil Medical Surges with Record Dose Sales and Key Regulatory Wins in Q3 FY25
5:54am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
OncoSil Medical Surges with Record Dose Sales and Key Regulatory Wins in Q3 FY25
5:54am on Monday 2nd of June, 2025 AEST
Key Points
Record quarterly dose sales up 233% year-on-year in Q3 FY25
Year-to-date revenues surged 135%, surpassing full FY24 figures
Received $1.05 million R&D tax incentive supporting ongoing development
Achieved EU Medical Device Regulation (MDR) approval, easing market access
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
OSL
OPEN ARTICLE